®
About Us
Founded in 2014, BLD Pharmatech Ltd. is a leading supplier and manufacturer of research chemicals to pharmaceutical companies, universities, biotech companies,healthcare industries,contract research organizations etc.
With its own R&D center in Shanghai, BLD Pharmatech Ltd. main field of expertise covers the development and production of heterocycles,boronic acids, amino acids, metal catalysts and chiral compounds.
Qualifications
BD261001[1073353-60-2]N-(2-Methoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide*
Specific Information
| Purity : | 98% | Specific Rotation : | |
| NMR(H/C/F/S/P) : | E.E. : | ||
| HPLC : | Water Content : | ||
| Polymerization Inhibitor : | Single Impurity : | ||
| Melting Point : | Density : | ||
| Packaging : | Solubility : | ||
| Name Note : | Acetic Acid : | ||
| Beilstein : | Grade : | ||
| Specific Gravity : | Viscosity : | ||
| Others : | |||
Product Details
| Cat No. : | BD261001 | Synonyms : | N-(2-Methoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide |
| CAS No. : | 1073353-60-2 | MDL NO : | MFCD09266188 |
| Formule : | C16H24BNO4 | InChI Key : | N/A |
| M.W : | 305.18 | Pubchem ID : | 46739044 |
| Boiling Point : | |||
Safety
| Signal Word : | Warning | Class : | N/A |
| Precautionary Statements : | P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501 | UN# : | N/A |
| Hazard Statements : | H302-H315-H319-H335 | Packing Group : | N/A |
| GHS Pictogram: | |||
R&D Center
- +CONTACT
TM
Copyright © 2013-2024 BLDpharm. All Rights Reserved.
Research Use Only!